quantisnow
FeedTopReportsPricing
⌘K
Live feed
14:56:36·255d
INSIDERFiling
Calamos Convertible Opportunities and Income Fund logo

FormerChief Compliance Officer Mickey Mark sold $10,360 worth of shares (1,000 units at $10.36), closing all direct ownership in the company (SEC Form 4)

CHI· Calamos Convertible Opportunities and Income Fund
Finance
Original source

Companies

  • CHI
    Calamos Convertible Opportunities and Income Fund
    Finance

Related

  • PR22d
    Calamos Investments Closed-End Funds (NASDAQ: CHI, CHY, CSQ, CGO, CHW, CCD and CPZ) Announce Monthly Distributions and Required Notifications of Sources of Distribution
  • PR52d
    Calamos Investments Closed-End Funds (NASDAQ: CHI, CHY, CSQ, CGO, CHW, CCD and CPZ) Announce Monthly Distributions and Required Notifications of Sources of Distribution
  • PR80d
    Calamos Investments Closed-End Funds (NASDAQ: CHI, CHY, CSQ, CGO, CHW, CCD and CPZ) Announce Monthly Distributions and Required Notifications of Sources of Distribution
  • SEC100d
    SEC Form N-CEN filed by Calamos Convertible Opportunities and Income Fund
  • SEC115d
    SEC Form N-CSR filed by Calamos Convertible Opportunities and Income Fund
  • PR126d
    Calamos Investments Closed-End Funds (NASDAQ: CHI, CHY, CSQ, CGO, CHW, CCD and CPZ) Announce Monthly Distributions and Required Notifications of Sources of Distribution
  • PR143d
    Calamos Investments Closed-End Funds (NASDAQ: CHI, CHY, CSQ, CGO, CHW, CCD and CPZ) Announce Monthly Distributions and Required Notifications of Sources of Distribution
  • PR171d
    Calamos Investments Closed-End Funds (NASDAQ: CHI, CHY, CSQ, CGO, CHW, CCD and CPZ) Announce Monthly Distributions and Required Notifications of Sources of Distribution
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022